IFP Advisors, Inc - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 441 filers reported holding REPLIGEN CORP in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2023$1,569
+2860.4%
36
-84.3%
0.00%
-100.0%
Q4 2022$53
-99.9%
230
+1.3%
0.00%0.0%
Q3 2022$51,000
+30.8%
227
+34.3%
0.00%0.0%
Q2 2022$39,000
-22.0%
169
-43.5%
0.00%0.0%
Q1 2022$50,000
+42.9%
299
+137.3%
0.00%0.0%
Q4 2021$35,000
-92.1%
126
-91.7%
0.00%
-88.9%
Q3 2021$441,000
+32.0%
1,524
-8.3%
0.01%
+28.6%
Q2 2021$334,000
-29.1%
1,662
-30.9%
0.01%
-22.2%
Q1 2021$471,000
-3.7%
2,405
-5.9%
0.01%
-55.0%
Q4 2020$489,000
+128.5%
2,557
+76.7%
0.02%
+53.8%
Q3 2020$214,000
+21.6%
1,447
-2.6%
0.01%
-7.1%
Q2 2020$176,000
+27.5%
1,486
-0.9%
0.01%0.0%
Q1 2020$138,000
-6.8%
1,499
-4.6%
0.01%
+27.3%
Q4 2019$148,000
+21.3%
1,572
-0.1%
0.01%
+37.5%
Q3 2019$122,000
+69.4%
1,574
+12.4%
0.01%
+100.0%
Q4 2018$72,000
-14.3%
1,400
-7.1%
0.00%
+33.3%
Q3 2018$84,000
+18.3%
1,5070.0%0.00%0.0%
Q2 2018$71,000
+29.1%
1,5070.0%0.00%
+50.0%
Q1 2018$55,0000.0%1,5070.0%0.00%0.0%
Q4 2017$55,000
-5.2%
1,5070.0%0.00%0.0%
Q3 2017$58,000
-6.5%
1,5070.0%0.00%
-33.3%
Q2 2017$62,000
+17.0%
1,5070.0%0.00%
+50.0%
Q1 2017$53,000
+15.2%
1,5070.0%0.00%0.0%
Q4 2016$46,000
+9.5%
1,507
+7.6%
0.00%0.0%
Q3 2016$42,000
+10.5%
1,4000.0%0.00%0.0%
Q2 2016$38,000
-5.0%
1,4000.0%0.00%
-33.3%
Q4 2015$40,0001,4000.00%
Other shareholders
REPLIGEN CORP shareholders Q2 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders